论文部分内容阅读
癌性脑膜病病人用氨甲喋呤(MTX)行鞘内化疗后,导致截瘫的发生率很低,临床报道也很少。我院近20年来收治的癌性脑膜病行鞘内化疗的病人有245例,发生截瘫7例,占2.85%,本文就截瘫的发生原因作一分析。1 临床资料一般资料:7例截瘫病人中,男5例,女2例,年龄最小17岁,最大67岁,平均年
The incidence of paraplegia after intrathecal chemotherapy with methotrexate (MTX) in patients with cancerous meningitis is very low, and clinical reports are rare. In our hospital in the past 20 years, there have been 245 patients undergoing intrathecal chemotherapy for cancer meningeal disease, and 7 cases of paraplegia occurred, accounting for 2.85%. This article analyzes the causes of paraplegia. 1 General clinical data: 7 paraplegic patients, 5 males and 2 females, youngest 17 years old, maximum 67 years old, average years